PGRMC1 and cancer: In human cancer cells, mutation of PGRMC1 phosphorylation sites leads to changes in PI3K/Akt activity, glucose metabolism, epigenetic genomic CpG methylation, and mitochondrial structure and function, leading to attenuated cancer growth and alterations to signaling pathways associated with pattern establishment and cell differentiation.